What Is Trace Tricuspid Regurgitation?

Trace tricuspid regurgitation is a tiny amount of blood leaking backward through the tricuspid valve during each heartbeat, detected on an echocardiogram. It sits at the very bottom of the severity scale and is so common in healthy people that most cardiologists consider it a normal finding rather than a disease. A color-flow Doppler study of 118 healthy volunteers found tricuspid regurgitation in about two-thirds of them, and the severity was uniformly trivial to mild.¹ Understanding what the term means, why it shows up on reports, and when it does or does not matter can save you a lot of unnecessary worry.

How the Tricuspid Valve Works

Your heart has four chambers, and the tricuspid valve sits between the two on the right side: the right atrium (which receives blood returning from the body) and the right ventricle (which pumps that blood toward the lungs). The valve has three thin flaps, or leaflets, that open to let blood flow from the atrium into the ventricle and then snap shut when the ventricle contracts. That closure is what keeps blood moving in one direction. When the leaflets don’t seal perfectly, a small jet of blood slips backward into the atrium. That backward flow is regurgitation.²

“Trace” is the smallest amount detectable. The grading scale runs from trace (sometimes called trivial or physiological) through mild, moderate, and severe. Trace regurgitation produces such a thin, brief jet of backflow that it has no measurable effect on heart function. The right atrium barely notices the extra trickle, and neither do you.

How Common Trace Tricuspid Regurgitation Really Is

Calling it “common” undersells it. Among adults, multiple studies have shown that the majority of people with structurally normal hearts have at least a whisper of tricuspid regurgitation when you look closely enough with modern Doppler equipment. One study reported that over 80 percent of adults have mild or trivial tricuspid regurgitation.³ The landmark color-flow study of healthy volunteers found it in 65 percent overall, but the rate climbed to 74 percent in the older age group, confirming that aging nudges the prevalence upward.¹

Children show the same pattern. A large pediatric echocardiography study found that over 90 percent of healthy children had some degree of tricuspid regurgitation, and the investigators concluded that mild tricuspid regurgitation should not be considered pathological in this group and does not require follow-up.³ A separate study of children with structurally normal hearts using color Doppler detected tricuspid regurgitation in about 6 percent, a lower figure largely because that study used stricter detection criteria, but still enough to establish that the finding appears routinely in healthy pediatric hearts.⁴

The wide range in reported prevalence (from single digits to over 90 percent) tells you something important: what you find depends on how sensitive your equipment is and how carefully you look. Better machines and more experienced sonographers pick up smaller jets. That sensitivity is the main reason trace tricuspid regurgitation shows up on so many echocardiogram reports today compared with decades ago.

Why a Tiny Leak Happens in a Normal Heart

The three leaflets of the tricuspid valve are thinner and more flexible than those on the left side of the heart, and the ring of tissue they attach to (the annulus) is naturally a little stretchy. During contraction, the leaflets have to come together perfectly to form a seal. In practice, a microscopically incomplete seal is normal. The pressures on the right side of the heart are much lower than those on the left, so even a slightly imperfect closure produces only a trivial backflow jet that the heart easily compensates for.

Breathing itself affects how much regurgitation a machine picks up. When you inhale, blood rushes into the right side of the heart, temporarily stretching the annulus a fraction more and potentially increasing the tiny jet. Doppler measurements of tricuspid regurgitation velocity can fluctuate noticeably between inhaling and exhaling, a phenomenon that has been carefully studied in patients with more significant regurgitation but that also applies, on a smaller scale, to trace jets.⁵ Body position, hydration status, and even a full meal can shift the amount of blood returning to the right heart and subtly change what the echo captures in that moment.

Primary Versus Secondary Tricuspid Regurgitation

When tricuspid regurgitation goes beyond trace or mild and becomes clinically significant, doctors classify it by cause. Primary tricuspid regurgitation means something is physically wrong with the valve itself: a leaflet torn by infection, a congenital malformation, or damage from a pacemaker lead threading through the valve.⁶ Secondary (or functional) tricuspid regurgitation means the valve’s structure is intact but the annulus has stretched or the right ventricle has enlarged, pulling the leaflets apart so they can no longer meet. Left-sided heart disease is the most frequent driver of this stretching process.⁷

None of this applies to trace tricuspid regurgitation in an otherwise healthy heart. The distinction matters, though, because if your echocardiogram shows trace regurgitation alongside other findings like an enlarged right ventricle or elevated pulmonary pressures, the cardiologist will pay attention to those other findings and may want to track whether the regurgitation progresses.

Does Trace Tricuspid Regurgitation Ever Get Worse?

For the vast majority of people, trace tricuspid regurgitation stays trace. It is a stable quirk of normal physiology, not the first step on a conveyor belt toward heart failure. That said, some conditions can push regurgitation from trace to mild, and eventually from mild to moderate or severe. Pulmonary hypertension, left-sided valve disease, atrial fibrillation, and chronic lung disease all raise pressures or stretch the right side of the heart in ways that gradually worsen the leak.

A large study in older adults (the ARIC cohort) found that about 62 percent had no or trivial tricuspid regurgitation, 29 percent had mild, 7 percent had moderate, and just 1 percent had severe. Higher severity was linked to a greater risk of developing heart failure, even after accounting for other heart problems. Prevalence and severity increased with age, even within this already older group.⁸ A separate surgical cohort study found that moderate and severe tricuspid regurgitation carried a clearly higher mortality risk, while mild tricuspid regurgitation showed only a borderline trend toward increased risk that did not reach statistical significance after adjusting for other factors.⁹

The takeaway is that the severity grade matters a lot for prognosis, and trace sits comfortably at the bottom of the risk scale. Progression from trace to something worrisome typically requires another cardiac problem to act as the engine.

Athletes and the Larger-Than-Average Heart

Endurance athletes regularly turn up with trace or mild tricuspid regurgitation at higher rates than non-athletes, and researchers have a clear explanation for why. Intense training enlarges the heart’s chambers and increases the volume of blood pumped with each beat. These adaptations stretch the tricuspid annulus just enough to allow a small regurgitant jet during systole. One study found valve regurgitation in at least one valve in 91 percent of athletes compared with 38 percent of controls, with tricuspid regurgitation present in 76 percent of athletes versus just 15 percent of controls.¹⁰ The researchers emphasized that this does not imply structural valve damage; it is a functional consequence of a heart that has remodeled to handle high workloads.

Separate work confirmed that tricuspid regurgitation velocity, stroke volume, and cardiac output are all higher in athletes than in non-athletes both at rest and during exercise.¹¹ This is relevant because if a competitive athlete gets an echocardiogram for an unrelated reason and the report mentions trace or mild tricuspid regurgitation, the finding alone should not raise alarms. The broader picture of vigorous training causing structural and functional cardiac adaptations, including changes to the atrioventricular valves, is well established.¹²

Trace Tricuspid Regurgitation Detected Before Birth

Advances in prenatal ultrasound, particularly color Doppler, have made it possible to spot tricuspid regurgitation in a fetus. This understandably alarms expecting parents when it shows up on a routine scan. But much of the increased detection rate reflects better imaging technology and the occasional lucky angle during the exam rather than a genuine increase in fetal heart problems.¹³

In low-risk pregnancies, isolated mild or trace fetal tricuspid regurgitation often resolves on its own before or shortly after birth. It can, however, sometimes accompany chromosomal abnormalities or structural heart defects, which is why doctors evaluate the finding in context. If the rest of the anatomy scan is normal and there are no other risk markers, an isolated trace finding is generally reassuring. When there is any doubt, a follow-up fetal echocardiogram with a pediatric cardiologist provides a more detailed look.

Why It Shows Up on Your Report (and What to Do About It)

Echocardiogram reports are written to document everything the machine detects, not just things that are clinically meaningful. Sonographers and reading physicians include trace findings because completeness matters in a medical record. Unfortunately, that means patients sometimes receive reports listing “trace tricuspid regurgitation” with no accompanying explanation that this is essentially the cardiac equivalent of a benign freckle.

If your report says trace tricuspid regurgitation and the rest of the echocardiogram is normal, here is what you can generally expect:

No symptoms: Trace regurgitation produces no chest pain, shortness of breath, fatigue, swelling, or any other symptom. If you have those symptoms, they are coming from something else.
No treatment: There is no medication, procedure, or lifestyle change indicated for trace tricuspid regurgitation itself.
No routine follow-up for the valve: Unless you have another heart condition being monitored, trace tricuspid regurgitation alone does not require repeat echocardiograms.
No activity restrictions: You do not need to limit exercise, avoid heavy lifting, or modify your daily routine based on this finding.

The situation changes if your echo report also mentions things like a dilated right ventricle, elevated pulmonary artery pressure, reduced heart function, or other valve abnormalities. Those findings together could suggest an underlying condition that happens to produce a small regurgitant jet as one of its effects. In that case, the follow-up is about the underlying condition, not about the trace jet itself.

When the Grade Might Be Underestimated

One thing worth knowing is that echocardiographic grading of tricuspid regurgitation can be tricky. The right side of the heart sits directly behind the breastbone and is harder to image clearly than the left side. Patient body habitus, lung interference, and the angle of the ultrasound beam all affect how large or small a regurgitant jet appears on screen. A jet graded as trace on one study could plausibly be graded as mild on another performed the same week by a different sonographer with a slightly different probe angle. The reverse can happen too.

This grading variability has practical implications. If you get an echo this year that says trace and one next year that says mild, that does not necessarily mean your valve has gotten worse. It might just mean the imaging conditions were slightly different. Cardiologists know this and generally look at the overall trend across multiple studies along with other measurements of heart size and function, rather than reacting to a single-grade shift in isolation.

Aging, the Annulus, and the Slow Drift

As you get older, the connective tissue in your heart, like connective tissue everywhere in the body, gradually loses some of its stiffness and elasticity. The tricuspid annulus tends to dilate slightly with age, which is one reason that the prevalence of tricuspid regurgitation climbs in older populations. In the ARIC study of older adults, prevalence and severity increased with advancing age even within a cohort that was already in late life.⁸ The color-flow study of healthy volunteers likewise showed a jump from 57 percent in younger adults to 74 percent in older adults.¹

For most people, this age-related drift stays within the trace-to-mild range and never becomes clinically significant. It helps to think of it in the same way you might think about a few gray hairs: a normal marker of time passing, not a medical problem requiring intervention. The people in whom tricuspid regurgitation progresses to moderate or severe typically have additional cardiac risk factors such as atrial fibrillation, pulmonary hypertension, or left-sided valve disease pushing the process along. Trace tricuspid regurgitation in a healthy older adult, absent those drivers, remains a benign incidental finding.

The Anxiety Gap

Cardiologists sometimes call trace tricuspid regurgitation a “report-ogenic” finding, meaning the report itself generates more distress than the finding warrants. Online health forums are full of worried posts from people who spotted the phrase on their echocardiogram results and immediately assumed something was wrong with their heart. The gap between the clinical significance (essentially zero) and the emotional impact (sometimes considerable) is real and worth acknowledging.

Part of the problem is that the word “regurgitation” sounds alarming. It implies something going in the wrong direction, which it is, but on a scale so small that the heart doesn’t even register it. Another part of the problem is that patients frequently read echo reports before their doctor has a chance to explain the results. If you find yourself in that situation, knowing that the majority of healthy people would have the same finding on their report is the most useful piece of context you can carry into the conversation with your cardiologist.